TimTec History Highlights 1995: TimTec Corporation was established in USA, Delaware as a distributor...
-
Upload
virgil-curtis -
Category
Documents
-
view
217 -
download
2
Transcript of TimTec History Highlights 1995: TimTec Corporation was established in USA, Delaware as a distributor...
TimTec History Highlights 1995: TimTec Corporation was established in USA, Delaware as a
distributor of Zelinsky Institute (Moscow, Russia) and also began providing compounds weighing and handling services
1996-97: TimTec expands compound sources to numerous research centers around the world
1998-2004: Cheminformatics technology development, database management, broadened supplier sources; became one-stop shopping vendor for screening compounds; partnership with Sigma-Aldrich (LOPAC), BioMol (MaxiVerse), Nacalai Tesque.
2005-2007: 10-year anniversary. New products: ApexScreen, Natural Products and MyriaScreen (Sigma-Aldrich). Collaboration with EnBioTec, Japan, screening, lead discovery project.
TimTec
Headquarters in Newark, Delaware, USA Operations Database management Marketing and business development Supplier network management Computational services
Compound management and storage facilities Liquid handling, labeling and bar-coding
services Currently expanding facility, personnel and
instrumentation to fulfill needs of growth
TimTec Key Contacts Dr. Murat Niyazymbetov - President and CEO
B.S., Mendeleev University, Ph. D., Zelinsky Institute. Worked at Zelinsky Institute of Organic Chemistry, University of Delaware, Electrosynthesis Company; more than 70 scientific publications.
Ms. Kay Denisova - Marketing and Bus. Dev., TimTec Products and Services Consulting. [email protected], 1 302 292 8500 x 202
Dr. Robert J. Chorvat - Medicinal Chemistry Business Development, Consulting. 15 Years DuPont Pharmaceuticals; 18 Years Searle/Pharmacia; 40 publications, 36 US patents.
Mr. Tim Niazoff - Director, Information Technology, Software Products and Computational Services [email protected], 1 302 292 8500 x 203
Mr. Olga Niazoff – VP Finance and Accounting. [email protected], 1 302 292 8500 x 204
TimTec Products Compound libraries
General screening Targeted Diversity Template-based Privileged structure Custom Libraries
Individual compounds Natural Products
Pure individual compounds Plant extracts Semi-natural and Derivatives
Building blocks and intermediates
TimTec Database Accessibility
Commercial Vendors
TimTec Database
Over 5 Million compounds
Non-exclusive chemiststhroughout Europe/Asia
TimTec-exclusive Chemists throughout
Europe/Asia
ACD Databaseand others
Compounds characteristics
Individually synthesized Purity - at least 90%, average 95% NMR (300 MHz or higher) and MS Possess drug-like properties Molecular Weight 160 - 600 No reactive groups No heavy metals Available in vials and/or 96/384-well plates
Lipinski Rule of Five Distribution
Lipinski Rule of Five Distribution
2 61
91
1
2
3
4
•Molecular mass not greater than 500•LogP not greater than 5•No more than 5 hydrogen bond donors•No more than 10 hydrogen bond acceptors
Molecular Weight Distribution
Molecular Weight Distribution
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
50 205 305 405 505 605 708 877
Molecular Weight
Per
cen
t o
f C
om
po
un
ds
Libraries Overview
TimTec libraries are characterized according to the following features that may overlap from collection to collection:
General screening collections, which would include specifically drug-like and generally diverse selections
Targeted, specialty compound collections, ActiTarg Series, template based, etc.
Nature Inspired: pure natural material or natural product derivatives and plant extracts
Different size: There are collections of 5,000cmpds, 10,000cmpds, 25,000cmpds, 50,000cmpd, or even 75-100,000cmpds. The latter would be grand ActiMol collection, our primary stock
Custom: collections selected based on suggested criteria Formatting options: compounds in dry form or in solutions
Diversity Libraries
A selection of compounds from currently available stock that represents the greatest chemical diversity for a specific number of compounds from that library
Proprietary software is used for these selections Available Diversity Libraries:
ActiGlobe 50K ActiProbe 25K, 10K ApexScreen 5040 RareCSC (under dev.) MyriaScreen (Sigma-Aldrich) MaxiVerse (BIOMOL)
ActiGlobe-50K
The grand diversity collection of 50,000 compounds has been assembled from world wide sources numbering over 2,000,000 compounds-candidates. The collection has molecules representing the chemical diversity of screening samples produced by labs and research centers throughout the world.
In addition to adherence to Lipinski parameters, dozens of
advanced filters have eliminated undesirable atoms, functionality and fragments creating a library that will provide exceptionally good chemical starting points for hit and ADMET optimization.
Due to large file size, ActiGlobe-50K database is available on
request for online download. Please call 1 302 292 8500 x 203 or e-mail at [email protected]
ActiProbe-10K and 25K Screening sets of 10,000 and 25,000 compounds respectively
originated from ActiGlobe-50K library. Both collections were selected through Jarvis-Patrick clustering. The overlap between ActiProbe-10K and ActiProbe-25K is about 4,500 compounds. Jarvis-Patrick clustering permits sampling of large library pools through selection of molecules that are representative of a group (cluster) within this library.
Molecular characterization is based on 2D fragment descriptors consisting of a central atom and neighboring atoms connected to it within a predefined sphere size -- bonds between central and edge atoms. Groups of molecules are based on the structural similarity of fingerprints (bit strings of these fragments), and the centroid has the highest degree of similarity to other members of a cluster. Chemically unique compounds (singletons) with low similarity to other members of the collection are also identified. Sampling libraries are created from centroid and singleton selection along with augmentation with other members from the largest groups.
MyriaScreen
Superior structural diversity - Distinct drug-like properties MyriaScreen was created by combining medicinal chemistry expertise and decades of experience in
compound acquisition from diverse sources. TimTec’s proprietary software was used to filter a pool of over 300,000 TimTec and Sigma-Aldrich compounds on the basis of diversity. Additional filters were set to consider MW (>225 and <600), cLogP, H-acceptor, H-donors, and rotatable bonds. Medicinal chemistry specialists refined the selection with great personal attention to remove compounds that were overly represented or not well suited for medicinal chemistry follow-up. MyriaScreen is rich in chemotypes and a valuable source of screening compounds for lead discovery.
Ready-to-use format - High purity - Efficient re-supply MyriaScreen is pre-plated for your convenience, 0.5 mg in 250 µL of DMSO per well. The compounds have an
average purity > 95% with nothing below 90%. Should you require more material for follow-up, re-supply or re-synthesis is available. Although MyriaScreen is designed for use as a complete set, there are two alternative options to fit your purchasing needs. Compounds can be purchased as individual plates or cherry-picked and plated on a custom basis.
Formatting Options Available:
The collection is pre-plated in 96-well plates and is available on request. There are 10,000 compounds, 0.5mg or 0.25mg per sample in DMSO solution.
0.5 mg in 250 mcL of DMSO is priced at $40,000.00 0.25mg in 125 mcL of DMSO solution is $24,500.000.05mg in 50 mcL of DMSO solution is $12,500.00
In pre-plated sets we have 1 and 12th columns empty.
Diversity SetIt is our most popular competitively priced collection of 10,000 most diversecompounds selected from TimTec stock of over 120,000 compounds.
Diversity Set is a superior collection in terms of diverse selection ofsingletons identified within variety of chemo types in TimTec stock:
2micromol or 1mg samples size in dry form is $53,000.005micromol or 2mg sample size in dry form is $64,750.000.5mg sample size is $31,000.001mg samples size is $47,000.00
On your request we can dissolve compounds in DMSO.Lead time applies.
ActiProbe10K, Diversity Set, and MyriaSreen Collection do not overlap in compound selection. Diversity Set is primarily diverse selection from our stock, variety of chemotypes is above all in focus. ActiProbe10K as entire collection strictly adheres to Lipinski rule of five, drug-likeness is in focus.
ApexScreen 5040 ApexScreen is a collection of 5,040 compounds that were selected to represent the diversity of TimTec
stock of over 120,000 compounds in a smaller format as opposed to larger general screening collections. ApexScreen in a variety of formatting options tailored to customer requirements is a perfect collection to jump-start any screening project.
ApexScreen was created with assistance of TimTec's Diversity Analysis Software that allows the assembly of libraries with maximized chemical diversity from databases of compounds that are currently available from TimTecUS and/or overseas stock. Diversity libraries can be further filtered to include molecules that fall within designated MW, cLogP and Lipinski Rule parameters. TimTec can also provide a selection of compounds from its databases which will include only those compounds that will contribute to the diversity of an existing customer library.
In addition to diverse selection of compounds that represent variety of chemotypes in TimTec general stock collection, ApexScreen includes a number of pure natural compounds from TimTec Natural Product Library to suit current trends in screening.
ApexScreen is a perfect collection for starting any screening project and a valuable addition to any existing compound library:
Various formatting option in terms of sample size or concentration are available: 5040 compounds: 0.5mg dry form, $16,800.00, Pre-plated in 96 well plates with removable tubes, rows 1&12th are empty. 0.25mg in DMSO, $11,500.00 0.1mg in DMSO, $8,600.00
Targeted Libraries
Molecules with molecular scaffolds found in agents reported in the technical/patent literature with the following biological properties: Kinase modulation GPCR binding Protease inhibition K-Channel Modulation Anti-Infectives
NP Scaffold for a Series of Inhibitors in the Kinase Family
An example: Comprising Targeted Library: ActiTarg-Series
A compound library developed around nakijiquinones, natural inhibitors of the receptor tyrosine kinase called Her-2/Neu, produced analogs that inhibit two other receptor tyrosine kinases, VEGFR-3 and Tie-2.
H. Waldmann et al.,J. Med. Chem., 46, 2917 (2003).
ActiTarg Series Targeted Libraries Our Kinase library, ActiTarg-K, includes over 6,600 drug-like compounds with low molecular
weight that have the ability to inhibit protein kinases. This diverse kinase collection includes samples-analogs with chemical lattices that match the chemical lattices found in compounds with already tested kinase activities, which were reported in scientific literature.
You can see the table of kinase and lattice types at: http://www.timtec.net/actitarg-k-kinase-modulators.html
GPCR ligands library, ActiTarg-G, currently has 2900 compounds. These agents possess chemical lattices present in compound types reported in the patent or
chemical literature to have various kinase inhibitory activities, as described on our web site: http://www.timtec.net/actitarg-g-gpcr-ligands.html
To meet the interest and needs of investigators who are trying to identify low molecular weight, drug-like molecules with the ability to inhibit various proteases, TimTec has assembled a library of compounds with potential protease inhibitory activity, ActiTarg-P. These are about 2,000 compounds in the collection:
http://www.timtec.net/actitarg-p-protease-inhibitors.html Potassium Channel Modulators, over 800 cmpds: http://www.timtec.net/potassium-channel-modulators.html
ActiTarg-S, Serine Proteinase Inhibitors Library Serine Proteinase Inhibitors Library collection includes analogs to a group of
serine proteinase inhibitors (serpins) that are known to be similar in amino acid sequence and mechanism of inhibition, yet differentiate in their specificity toward proteolytic enzymes as it is reported in technical literature.
For instance, the groups of known serpins among others include: alpha 1-antitrypsin, angiotensinogen, ovalbumin, antiplasmin, alpha 1-antichymotrypsin, thyroxine-binding protein, complement 1 inactivators, antithrombin III, heparin cofactor II, plasminogen inactivators, gene Y protein, placental plasminogen activator inhibitor.
TimTec collection currently includes about 450 close analogs to known serpins. Entire collection in 1mg is $28.00 per compound. We may also select top diversity compounds and arrange them into plates: 80
compounds in 0.5mg size plated in 96-well plates with removable tubes, columns 1 & 12 left empty:
3 plates, 240cmpds is $4,560.004 plates, 320cmpds is $5,920.005 plates, 400cmpds is $7,300.00
Fragment-Based Library
Low molecular weight Low binding affinity to a drug target High solubility clogP <= 3 Rotable bonds <=5 HBA <=3 and HBD<=3
Privileged Structure Library Evaluation of the structures of pharmaceuticals and
agents with good pharmacological activity led to identification of molecular substructures frequently associated with a higher level of biological activity.
These motifs were given the "privileged" label when they were found to be present in molecules that were active at two or more different receptors. Aza-(and diaza-)biphenyls Benzhydryl compounds Biphenyls Dihydropyridines Anilino-pyridine, pyrimidine, or triazines Phenylpiperazines Flavonoids
Natural Product Library Diversity by nature Purity by science Value by design
Natural Product Library now includes 480 pure individual natural compounds:
From Rediscovering Natural Products article published in Chemical and Engeneering News, why the interest in natural compounds is increasing:
1) Combinatorial chemistry's promise to fill drug development pipelines with de novo synthetic small-molecule drug candidates is unfulfilled
2) The practical difficulties of natural products drug discovery are being overcome by advances in separation technologies and in the speed and sensitivity of structure elucidation
3) A compelling case is being made for the intrinsic utility of natural products as sources of drug leads.
TimTec has assembled a library of natural products and naturalproduct-derived compound that provide a broad selection of molecularframeworks that probe chemical diversity space.
Solids or freshly prepared DMSO solutions:
0.5mg set is $5,500.001mg set is $7,850.00 2mg set is $11,450.00 3mg/$14,950.00
0.05mg in 25 microliters of DMSO is $ 1,750.000.1 mg in 50 microliters of DMSO is $2,750.000.25 mg in 125 microliters of DMOS is $3,975.000.5mg in 250 microliters of DMSO is $5,500.00
Natural Product Derivatives
Several thousand NP-derived compounds are available in stock
A selection of about 4000 compounds has been assembled to provide a representation of the diversity of this collection
Price depends on the number of compounds selected and a sample size. Please inquire a quote.
Plant Extracts
About 9000 cataloged plants from various regions of the former USSR are available for collection
About 2500 dried plant species are in stock Extracts are available on large scale Fractionation and active component
identification services are possible
Custom Library TimTec can comprise compound collection of
different size (from few to thousands of compounds) utilizing proprietary software based on variety of custom criteria: structure similarity search, presence of a particular fragment/s, defined MW, clogP, number of HBA and HBD, Lipinski Rule, Rule of 3, etc.
TimTec can also provide a selection of compounds from its databases which will include only those compounds that will contribute to the diversity of an existing customer library. We will do database comparison and diversity analysis.
Please contact us to discuss customization options.
Additional Notes Price on compound libraries and custom selected collections including
cherry-picking would depend on the number of compounds selected and a sample size.
Custom formatting options are available for all of our libraries. Please refer to the compound management/handling section of this presentation.
Prices do not include shipping and cost of custom containers All compounds we have are stored in dry form and can be freshly
prepared in DMSO. Purity of compounds in our collections, on average is >/= 95% as
determined by high-field 1H-NMR and/or MS. Overall purity is at least 90%.
Compounds are available for re-supply from stock or after re-synthesis depending on amounts required. Exact amount available for re-supply will be confirmed at the time of re-order.
TimTec does not hold any IP rights on compounds we sell. Once a hit is identified it is yours for further development.
TimTec Services Compound Management Consolidated Compound Procurement Database management Computational Services Custom Synthesis Analytical
Sample Handling Services Custom weighing in dry form or freshly prepared in DMSO Preparation of storage, master and daughter (96-384 well) plates Barcode labeling using chemically resistant labels Conversion of existing libraries into HTS format Freezer storage of dissolved compounds and overnight shipment under dry ice Delivery of vials in 96-divider boxes
Multi-source database mining Single point-of-service ordering Preparation of appropriately formatted plates Uniform database processing Database management Possible vendor-to-vendor discounts
Consolidated Compound Acquisition
Analytical Services
LC/MS at TimTec location LC/GC/MS and HPLC: Currently partnering with
StereoChemicals in Delaware. 500 MHz instruments: available in US (Ohio State
University) to spot-check samples as needed High-throughput NMR: a high capacity network
(Moscow) of six instruments, 300 to 500 MHz, produces spectra in electronic (FID) and/or hard copy files
Computational Services
Vendor Database Acquisition and Management (e.g., duplication and availability determination)
Functional Group and Fragment Filtration Lipinski Parameter Assessment Library Comparisons (in-house vs. vendor) Database Clustering Database Comparison and Sorting by Diversity Prediction of lipophilicity (LogP and LogD)
Diversity Analysis of an External Library compared to an In-house Screening Collection
Size of in-house library: 561,633 compounds Size of vendor library: 133,622 compounds Duplicates identified: 6810 compounds Number of compounds that will maximize diversity of collection: ~65,000
TimTec Clients TimTec has served more than 700 pharmaceutical, biotech and
academic clients. To name a few:
Aldrich
Anadys
Aventis
AstraZeneca
Boehringer
Cetek
Dow Agro
DuPont
Eli Lilly
Evotec
Ferring
BMS
Glaxo
Amgen
NIH
Genome Therapeutics
Harvard Med
Kanto Chemicals
Mercury Therapeutics
Millennium
Novartis Pharma
Pfizer
Procter & Gamble
Schering – Plough
Serono
Syngenta
Scripps REs Inst
Sepracor
UCB
Unilever
For more information please visit www.timtec.net
Contact: 1-800-574-7391; 1-302-292-8500 Email: [email protected]
Contact TimTec